---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-064008"
form_type: "8-K"
ticker: "PEPG"
cik: "0001835597"
company_name: "PepGen Inc."
filed_at: "2023-11-15T23:59:59+00:00"
generated_at: "2026-06-08T02:43:13.621821+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# PepGen appoints Howard Mayer, M.D. to board of directors

## Summary
- Howard Mayer appointed to PepGen board effective Nov 15, 2023; fills newly created vacancy expanding board to seven members.
- Dr. Mayer will receive initial option for 22,686 shares under 2022 Stock Plan; annual cash retainers $35k for board, $5k for compensation committee.
- Dr. Mayer was most recently EVP, Head of R&D at Ipsen Biopharmaceuticals (2019-2023); previously SVP, CMO at Shire Pharmaceuticals.
- He brings experience in rare disease clinical development and regulatory filings; will serve on Compensation Committee.
- No family relationships or arrangements with other persons regarding his appointment.

## SEC filing metadata
- accession: 0000950170-23-064008
- form_type: 8-K
- ticker: PEPG
- cik: 0001835597
- company_name: PepGen Inc.
- filed_at: 2023-11-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835597/000095017023064008/0000950170-23-064008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835597/000095017023064008/pepg-20231115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-064008
- JSON: https://secwatch.observer/filing/0000950170-23-064008.json
- Plain text: https://secwatch.observer/filing/0000950170-23-064008.txt

## Key facts
- Executive change
  Howard Mayer was appointed as Director at PepGen Inc..
  - Action: appointed
  - Role: Director
  source text: On November 10, 2023, the Board of Directors (the “Board”) of PepGen Inc. (“PepGen”) on the recommendation of the Nominating and Corporate Governance Committee of the Board, unanimously appointed Howard Mayer to fill a newly created vacancy on the Board resulting from the expansion of the number of members of the Board from six to seven.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835597/000095017023064008/0000950170-23-064008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.